Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Free Thinking: Behavioural economics

    March 27, 2015 |  

    Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

    Books espousing behavioural economic theories, such as “Thinking Fast and Slow” authored by Daniel Kahneman, have become essential reading for market researchers looking to improve their understanding of how people think, feel and behave.

    This theory can be very useful in consumer research, where we already know the power brands have on influencing purchase decisions. But can behavioural economics theory be applied to the pharmaceutical healthcare industry, where treatment decisions are often made in a highly regulated environment and by educated professionals using sound, rational judgement?

    Download and read the complimentary whitepaper at http://bit.ly/1L5YhyM

    We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges. 

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Research Partnership and Janssen are 2017-18 BOBI Awards finalists

    We are delighted to announce that an entry submitted by Research Partnership with Janssen has been selected as a finalist in the Best Business Impact category at this year’s BOBI...

    Portfolio analysis: Making Go/No-Go decisions to optimise the portfolio

    Tuesday 20th March 2018 11:00 EST / 16:00 GMT / 17:00 CEST

    PMRC New Jersey round up 2018

    Earlier this month, Directors Tom Nolte and Melinda Shorr attended the Pharmaceutical Market Research Conference in Newark, New Jersey

    Bringing sufferers out of the shadows – Reducing the emotional impact of living with Atopic Dermatitis

    You can probably remember at least one of your friends in school who was always scratching and suffered from red, scaly skin rashes, perhaps on their elbows or backs of...

    Good intentions, bad habits: Reforming mental healthcare in Latin America and the Caribbean

    In the second of a series of articles exploring mental health in emerging markets we take an in-depth look at the situation in Latin America and the Caribbean

    How we applied user-led design thinking in the ER setting to improve patient care

    The challengeOur client needed to identify the key delivery-device attributes for an antibiotic topical treatment used to combat a group of infections typically affecting young children. Current treatment is a...

    Research conducted by Research Partnership published in leading medical journal

    Findings from a study conducted by Research Partnership have recently been published in the ‘Supportive Care in Cancer’ journal

    Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist

    Hiding between the lines of any company’s ledgers is an intangible asset, invisible to most auditors, but with the potential to have a very real impact on bottom line. Pharma...

    Webcast: Rich in potential – Exploring the opportunity for nutritionals in emerging markets

    Watch the webcast: http://bit.ly/2oTpzFjA shift to preventative health has seen nutritionals emerge as a rapidly developing area in recent years. But while growth begins to level off in more established territories,...

    A researcher’s guide to Key Driver Analysis

    Research Manager Kayleigh Simpson explores how Key Driver Analysis can be used to answer key business